Global Rapid Tests Market By Type (Rapid Antigen Test, Rapid Antibody Test); By Format (Strips, Cassette, Card )By Type (Professional tests, Over The Counter Tests) By Application (General Health (Blood Gas Analysis (ABG Test), Haemoglobin Tests, Lipid Profile, Traumatic Brain Injury (TBI) Test, Others) STIs / GYN-OB (HIV, Hepatitis B, Hepatitis C, Pregnancy, Others); Infectious Diseases(RSV, Influenza, Streptococcus/Stepthroat, COVID-19 test, C-reactive protein (CRP) Test (Inflammation/Infection), Procalcitonin (PCT) Test (sepsis/bacterial infections), Others, Endocrine (Diabetes) (Rapid Blood Glucose Test, Hemoglobin A1c (HbA1c) Test, Ketone Test, Others) By End Users (Hospitals and Clinics, Laboratories, At-home testing, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
In Terms of Revenue, Global Rapid Tests Market was Valued at USD 1.35 Bn in 2022, expected to witness CAGR of 8.5% from 2023- 2031.
Rapid testing provides quick outcomes and frequently are less complicated than traditional molecular testing. They can process samples more quickly as a result. The quickest test currently available, ID NOW by Abbott, has a 13-minute or less detection time for viruses. Results from most fast tests are typically available in 15 to 30 minutes. Rapid tests can also be performed at point-of-care (such as the testing location or the provider's office). Additionally, they don't need an external laboratory to process samples. In order to finish the full procedure in one location, they frequently employ portable equipment to evaluate samples. Although rapid tests have been available for some time, the COVID-19 epidemic has expedited changes in how healthcare is provided and the demand for more advanced patient care has increased. Innovations that enable patients to make quicker, more informed decisions and aid healthcare systems in effectively addressing escalating health issues are urgently needed. For instance, in response to COVID-19, fast antigen tests were introduced to enable anybody, even those without any symptoms, to reliably and quickly diagnose the infection from any location. The tests take around 15 minutes to complete. In more than 140 countries, airports, schools, and government offices have employed the quick COVID-19 antigen testing, more than 300 million times to detect infectious people and stop the spread of infection. Rapid testing provides proactive, timely diagnosis and is advantageous to both patients and medical professionals when used with ongoing innovation and a planned strategy. The Global Viral Surveillance and Pandemic Defence Coalition programmes of Abbott continually evaluated viral mutations and improved diagnosis. In order to combat the rise of infectious illnesses and avert any potential pandemic risks, has enabled the larger scientific and medical community to recognise potential viral dangers and respond quickly when a new one is detected.
Global Rapid Tests Market Revenue & Forecast, (US$ Million), 2015 – 2031
Based on application, sexually transmitted diseases and obstetrics and gynecology segment had the highest share in the global rapid tests market in the year 2022. There has been rise in demand for rapid tests for STI as these tests can be done at home and give quick results. Many individuals prefer home testing, as it can be done privately and avoids the potential embarrassment of testing at a clinic. Rapid tests for sexually transmitted infections were created to save peoples time, effort and stress when testing for gonorrhea, chlamydia, and human immunodeficiency virus (HIV) and other sexually transmitted infections. Moreover, leading players in the rapid tests market are focusing on providing accurate results for better treatments. For instance, manufacturers are focusing on rapid pregnancy tests with advanced technologies that are more sensitive and efficient to improve the consumer experience. Over the years, vendors have introduced technological advanced products such as digital and saliva-based pregnancy test kits. Thus, with these factors the global rapid tests market will further upsurge during the forecast period 2023-2031.
North America had the highest share in the rapid tests market in the year 2022. Since Covid-19 there has been a huge demand for in-home rapid tests in United States. During the SARS-CoV-2 Delta- and Omicron-predominant phases, there was a sharp rise in the usage of at-home tests in the United States. When Americans start to experience symptoms, public health professionals and the Centers for Disease Control and Prevention advised the people on using at-home testing. The healthcare government organization bought one billion at-home, fast COVID-19 tests to deliver it to American population, to ensure that they have testing on hand in case a need arises. The United States has conducted around 1.15 billion COVID-19 tests as of December 22, 2022, the highest number of any country worldwide, which has resulted to the growth of rapid tests market in North America.
Competitive Landscape
The report provides both, qualitative and quantitative research of global rapid tests market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global rapid tests market are
- Abbott
- Active Scientific Sdn Bhd.
- Bio-Rad Laboratories, Inc.
- Creative Diagnostics
- CROWN CLINIC
- F. Hoffmann-La Roche Ltd
- Genes2Me
- JOYSBIO (Tianjin) Biotechnology Co., Ltd
- Malaysian Diagnostics Corporation.
- Mediven
- Precision Biomed
- Prima Dinamik Supplies Sdn Bhd.
- Robert Bosch Sdn Bhd
- SEKISUI Diagnostics
- Setia Scientific Solution
- Other Industry Participants
Global Rapid Tests Market:
By Type
- Rapid Antigen Test
- Rapid Antibody Test
By Format
- Strips
- Cassette
- Card
By Product Type
- Professional tests
- Over the counter
By Application
- General Health
- Blood gas analysis (ABG test)
- Haemoglobin tests
- Lipid profile
- Traumatic brain injury (TBI) test
- Others
- STIs / GYN-OB
- HIV
- Hepatitis B
- Hepatitis C
- Pregnancy
- Others
- Infectious Diseases
- RSV
- Influenza
- Streptococcus/Stepthroat
- COVID-19 test
- C-reactive protein (CRP) test (inflammation/infection)
- Procalcitonin (PCT) test (sepsis/bacterial infections)
- Others
- Endocrine (Diabetes)
- Rapid blood glucose test
- Hemoglobin A1c (HbA1c) test
- Ketone test
- Others
- Others
By End Users
- Hospitals and Clinics
- Laboratories
- At-home testing
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2021
1.2.2. Base Year: 2022
1.2.3. Forecast Years: 2023 – 2031
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Rapid Tests Market
6.
Market
Synopsis: Rapid Tests Market
7.
Rapid
Tests Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Rapid Tests Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Rapid Tests Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Rapid Tests Market
8.
Global
Rapid Tests Market Analysis and Forecasts, 2023 - 2031
8.1. Overview
8.1.1. Global Rapid Tests Market Revenue (US$ Mn)
8.2. Global Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Type
8.2.1. Rapid Antigen test
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.1.3.
Market
Forecast, 2023 - 2031
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2022
8.2.1.5.1.2. Market Forecast, 2023 - 2031
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2022
8.2.1.5.2.2. Market Forecast, 2023 - 2031
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2022
8.2.1.5.3.2. Market Forecast, 2023 - 2031
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2022
8.2.1.5.4.2. Market Forecast, 2023 - 2031
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2022
8.2.1.5.5.2. Market Forecast, 2023 - 2031
8.2.2. Rapid Antibody test
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.2.3.
Market
Forecast, 2023 - 2031
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2022
8.2.2.5.1.2. Market Forecast, 2023 - 2031
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2022
8.2.2.5.2.2. Market Forecast, 2023 - 2031
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2022
8.2.2.5.3.2. Market Forecast, 2023 - 2031
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2022
8.2.2.5.4.2. Market Forecast, 2023 - 2031
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2022
8.2.2.5.5.2. Market Forecast, 2023 - 2031
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Rapid Tests Market Analysis and Forecasts, 2023 - 2031
9.1. Overview
9.2. Global Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Format
9.2.1. Strips
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.1.3.
Market
Forecast, 2023 - 2031
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2022
9.2.1.5.1.2. Market Forecast, 2023 - 2031
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2022
9.2.1.5.2.2. Market Forecast, 2023 - 2031
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2022
9.2.1.5.3.2. Market Forecast, 2023 - 2031
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2022
9.2.1.5.4.2. Market Forecast, 2023 - 2031
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2022
9.2.1.5.5.2. Market Forecast, 2023 - 2031
9.2.2. Cassette
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.2.3.
Market
Forecast, 2023 - 2031
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2022
9.2.2.5.1.2. Market Forecast, 2023 - 2031
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2022
9.2.2.5.2.2. Market Forecast, 2023 - 2031
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2022
9.2.2.5.3.2. Market Forecast, 2023 - 2031
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2022
9.2.2.5.4.2. Market Forecast, 2023 - 2031
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2022
9.2.2.5.5.2. Market Forecast, 2023 - 2031
9.2.3. Card
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2022
9.2.3.3.
Market
Forecast, 2023 - 2031
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2022
9.2.3.5.1.2. Market Forecast, 2023 - 2031
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2022
9.2.3.5.2.2. Market Forecast, 2023 - 2031
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2022
9.2.3.5.3.2. Market Forecast, 2023 - 2031
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2022
9.2.3.5.4.2. Market Forecast, 2023 - 2031
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2022
9.2.3.5.5.2. Market Forecast, 2023 - 2031
9.3. Key Segment for Channeling Investments
9.3.1. By Format
10. Global Rapid Tests Market Analysis and
Forecasts, 2023 - 2031
10.1. Overview
10.2. Global Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Product Type
10.2.1. Professional tests
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
10.2.1.3.
Market
Forecast, 2023 - 2031
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2022
10.2.1.5.1.2. Market Forecast, 2023 - 2031
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2022
10.2.1.5.2.2. Market Forecast, 2023 - 2031
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2022
10.2.1.5.3.2. Market Forecast, 2023 - 2031
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2022
10.2.1.5.4.2. Market Forecast, 2023 - 2031
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2022
10.2.1.5.5.2. Market Forecast, 2023 - 2031
10.2.2. Over the counter tests
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
10.2.2.3.
Market
Forecast, 2023 - 2031
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2022
10.2.2.5.1.2. Market Forecast, 2023 - 2031
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2022
10.2.2.5.2.2. Market Forecast, 2023 - 2031
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2022
10.2.2.5.3.2. Market Forecast, 2023 - 2031
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2022
10.2.2.5.4.2. Market Forecast, 2023 - 2031
10.2.2.5.5.
Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2022
10.2.2.5.5.2. Market Forecast, 2023 - 2031
10.3. Key Segment for Channeling Investments
10.3.1. By Product Type
11. Global Rapid Tests Market Analysis and
Forecasts, 2023 - 2031
11.1. Overview
11.2. Global Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Application
11.2.1. General Health (Definition, Market Estimation
and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Blood gas analysis (ABG test), Haemoglobin tests, Lipid profile,
Traumatic brain injury (TBI) test, Others )
11.2.1.1.
Blood
gas analysis (ABG test)
11.2.1.2.
Haemoglobin
tests
11.2.1.3.
Lipid
profile
11.2.1.4.
Traumatic
brain injury (TBI) test
11.2.1.5.
Others
11.2.2. STIs / GYN-OB (Definition, Market Estimation
and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on HIV, Hepatitis B, Hepatitis C, Pregnancy, Others)
11.2.2.1.
HIV
11.2.2.2.
Hepatitis
B
11.2.2.3.
Hepatitis
C
11.2.2.4.
Pregnancy
11.2.2.5.
Others
11.2.3. Infectious Diseases (Definition, Market
Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market
Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on RSV, Influenza, Streptococcus/Stepthroat, COVID-19
test, C-reactive protein (CRP) test(inflammation/infection), Procalcitonin
(PCT) test (sepsis/bacterial infections), Others)
11.2.3.1.
RSV
11.2.3.2.
Influenza
11.2.3.3.
Streptococcus/Stepthroat
11.2.3.4.
COVID-19
test
11.2.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
11.2.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
11.2.3.7.
Others
11.2.4. Endocrine (Diabetes) (Definition, Market
Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022),
Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Rapid blood glucose test, Hemoglobin A1c (HbA1c)
test, Ketone)
11.2.4.1.
Rapid
blood glucose test
11.2.4.2.
Hemoglobin
A1c (HbA1c) test
11.2.4.3.
Ketone
11.2.5. Others
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2015 - 2022
11.2.5.3.
Market
Forecast, 2023 - 2031
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2015 - 2022
11.2.5.5.1.2. Market Forecast, 2023 - 2031
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2022
11.2.5.5.2.2. Market Forecast, 2023 - 2031
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2022
11.2.5.5.3.2. Market Forecast, 2023 - 2031
11.2.5.5.4.
Middle
East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2022
11.2.5.5.4.2. Market Forecast, 2023 - 2031
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2015 - 2022
11.2.5.5.5.2. Market Forecast, 2023 - 2031
11.3. Key Segment for Channeling Investments
11.3.1. By Application
12. Global Rapid Tests Market Analysis and
Forecasts, 2023 - 2031
12.1. Overview
12.2. Global Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By End Users
12.2.1. Hospitals and Clinics
12.2.1.1.
Definition
12.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
12.2.1.3.
Market
Forecast, 2023 - 2031
12.2.1.4.
Compound
Annual Growth Rate (CAGR)
12.2.1.5.
Regional
Bifurcation
12.2.1.5.1.
North
America
12.2.1.5.1.1. Market Estimation, 2015 - 2022
12.2.1.5.1.2. Market Forecast, 2023 - 2031
12.2.1.5.2.
Europe
12.2.1.5.2.1. Market Estimation, 2015 - 2022
12.2.1.5.2.2. Market Forecast, 2023 - 2031
12.2.1.5.3.
Asia
Pacific
12.2.1.5.3.1. Market Estimation, 2015 - 2022
12.2.1.5.3.2. Market Forecast, 2023 - 2031
12.2.1.5.4.
Middle
East and Africa
12.2.1.5.4.1. Market Estimation, 2015 - 2022
12.2.1.5.4.2. Market Forecast, 2023 - 2031
12.2.1.5.5.
Latin
America
12.2.1.5.5.1. Market Estimation, 2015 - 2022
12.2.1.5.5.2. Market Forecast, 2023 - 2031
12.2.2. Laboratories
12.2.2.1.
Definition
12.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
12.2.2.3.
Market
Forecast, 2023 - 2031
12.2.2.4.
Compound
Annual Growth Rate (CAGR)
12.2.2.5.
Regional
Bifurcation
12.2.2.5.1.
North
America
12.2.2.5.1.1. Market Estimation, 2015 - 2022
12.2.2.5.1.2. Market Forecast, 2023 - 2031
12.2.2.5.2.
Europe
12.2.2.5.2.1. Market Estimation, 2015 - 2022
12.2.2.5.2.2. Market Forecast, 2023 - 2031
12.2.2.5.3.
Asia
Pacific
12.2.2.5.3.1. Market Estimation, 2015 - 2022
12.2.2.5.3.2. Market Forecast, 2023 - 2031
12.2.2.5.4.
Middle
East and Africa
12.2.2.5.4.1. Market Estimation, 2015 - 2022
12.2.2.5.4.2. Market Forecast, 2023 - 2031
12.2.2.5.5.
Latin
America
12.2.2.5.5.1. Market Estimation, 2015 - 2022
12.2.2.5.5.2. Market Forecast, 2023 - 2031
12.2.3. At-home testing
12.2.3.1.
Definition
12.2.3.2.
Market
Estimation and Penetration, 2015 - 2022
12.2.3.3.
Market
Forecast, 2023 - 2031
12.2.3.4.
Compound
Annual Growth Rate (CAGR)
12.2.3.5.
Regional
Bifurcation
12.2.3.5.1.
North
America
12.2.3.5.1.1. Market Estimation, 2015 - 2022
12.2.3.5.1.2. Market Forecast, 2023 - 2031
12.2.3.5.2.
Europe
12.2.3.5.2.1. Market Estimation, 2015 - 2022
12.2.3.5.2.2. Market Forecast, 2023 - 2031
12.2.3.5.3.
Asia
Pacific
12.2.3.5.3.1. Market Estimation, 2015 - 2022
12.2.3.5.3.2. Market Forecast, 2023 - 2031
12.2.3.5.4.
Middle
East and Africa
12.2.3.5.4.1. Market Estimation, 2015 - 2022
12.2.3.5.4.2. Market Forecast, 2023 - 2031
12.2.3.5.5.
Latin
America
12.2.3.5.5.1. Market Estimation, 2015 - 2022
12.2.3.5.5.2. Market Forecast, 2023 - 2031
12.2.4. Others
12.2.4.1.
Definition
12.2.4.2.
Market
Estimation and Penetration, 2015 - 2022
12.2.4.3.
Market
Forecast, 2023 - 2031
12.2.4.4.
Compound
Annual Growth Rate (CAGR)
12.2.4.5.
Regional
Bifurcation
12.2.4.5.1.
North
America
12.2.4.5.1.1. Market Estimation, 2015 - 2022
12.2.4.5.1.2. Market Forecast, 2023 - 2031
12.2.4.5.2.
Europe
12.2.4.5.2.1. Market Estimation, 2015 - 2022
12.2.4.5.2.2. Market Forecast, 2023 - 2031
12.2.4.5.3.
Asia
Pacific
12.2.4.5.3.1. Market Estimation, 2015 - 2022
12.2.4.5.3.2. Market Forecast, 2023 - 2031
12.2.4.5.4.
Middle
East and Africa
12.2.4.5.4.1. Market Estimation, 2015 - 2022
12.2.4.5.4.2. Market Forecast, 2023 - 2031
12.2.4.5.5.
Latin
America
12.2.4.5.5.1. Market Estimation, 2015 - 2022
12.2.4.5.5.2. Market Forecast, 2023 - 2031
12.3. Key Segment for Channeling Investments
12.3.1. By End Users
13. North America Rapid Tests Market Analysis
and Forecasts, 2023 - 2031
13.1. Overview
13.1.1. North America Rapid Tests Market Revenue (US$
Mn)
13.2. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Type
13.2.1. Rapid Antigen test
13.2.2. Rapid Antibody test
13.3. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Format
13.3.1. Strips
13.3.2. Cassette
13.3.3. Card
13.4. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Product Type
13.4.1. Professional tests
13.4.2. Over the counter tests
13.5. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Application
13.5.1. General Health
13.5.1.1.
Blood
gas analysis (ABG test)
13.5.1.2.
Haemoglobin
tests
13.5.1.3.
Lipid
profile
13.5.1.4.
Traumatic
brain injury (TBI) test
13.5.1.5.
Others
13.5.2. STIs / GYN-OB
13.5.2.1.
HIV
13.5.2.2.
Hepatitis
B
13.5.2.3.
Hepatitis
C
13.5.2.4.
Pregnancy
13.5.2.5.
Others
13.5.3. Infectious Diseases
13.5.3.1.
RSV
13.5.3.2.
Influenza
13.5.3.3.
Streptococcus/Stepthroat
13.5.3.4.
COVID-19
test
13.5.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
13.5.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
13.5.3.7.
Others
13.5.4. Endocrine (Diabetes)
13.5.4.1.
Rapid
blood glucose test
13.5.4.2.
Hemoglobin
A1c (HbA1c) test
13.5.4.3.
Ketone
13.5.5. Others
13.6. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.1. Hospitals and Clinics
13.6.2. Laboratories
13.6.3. At-home testing
13.6.4. Others
13.7. North America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1.
U.S
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
13.7.1.1.1.
Rapid
Antigen test
13.7.1.1.2.
Rapid
Antibody test
13.7.1.2.
U.S
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
13.7.1.2.1.
Strips
13.7.1.2.2.
Cassette
13.7.1.2.3.
Card
13.7.1.3.
U.S
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
13.7.1.3.1.
Professional
tests
13.7.1.3.2.
Over the
counter tests
13.7.1.4.
U.S
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.4.1.
General
Health
13.7.1.4.1.1. Blood gas analysis (ABG test)
13.7.1.4.1.2. Haemoglobin tests
13.7.1.4.1.3. Lipid profile
13.7.1.4.1.4. Traumatic brain injury (TBI) test
13.7.1.4.1.5. Others
13.7.1.4.2.
STIs /
GYN-OB
13.7.1.4.2.1. HIV
13.7.1.4.2.2. Hepatitis B
13.7.1.4.2.3. Hepatitis C
13.7.1.4.2.4. Pregnancy
13.7.1.4.2.5. Others
13.7.1.4.3.
Infectious
Diseases
13.7.1.4.3.1. RSV
13.7.1.4.3.2. Influenza
13.7.1.4.3.3. Streptococcus/Stepthroat
13.7.1.4.3.4. COVID-19 test
13.7.1.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
13.7.1.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
13.7.1.4.3.7. Others
13.7.1.4.4.
Endocrine
(Diabetes)
13.7.1.4.4.1. Rapid blood glucose test
13.7.1.4.4.2. Hemoglobin A1c (HbA1c) test
13.7.1.4.4.3. Ketone
13.7.1.4.5.
Others
13.7.1.5.
U.S
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.1.5.1.
Hospitals
and Clinics
13.7.1.5.2.
Laboratories
13.7.1.5.3.
At-home
testing
13.7.1.5.4.
Others
13.7.2. Canada
13.7.2.1.
Canada
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
13.7.2.1.1.
Rapid
Antigen test
13.7.2.1.2.
Rapid
Antibody test
13.7.2.2.
Canada
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
13.7.2.2.1.
Strips
13.7.2.2.2.
Cassette
13.7.2.2.3.
Card
13.7.2.3.
Canada
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
13.7.2.3.1.
Professional
tests
13.7.2.3.2.
Over the
counter tests
13.7.2.4.
Canada
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.4.1.
General
Health
13.7.2.4.1.1. Blood gas analysis (ABG test)
13.7.2.4.1.2. Haemoglobin tests
13.7.2.4.1.3. Lipid profile
13.7.2.4.1.4. Traumatic brain injury (TBI) test
13.7.2.4.1.5. Others
13.7.2.4.2.
STIs /
GYN-OB
13.7.2.4.2.1. HIV
13.7.2.4.2.2. Hepatitis B
13.7.2.4.2.3. Hepatitis C
13.7.2.4.2.4. Pregnancy
13.7.2.4.2.5. Others
13.7.2.4.3.
Infectious
Diseases
13.7.2.4.3.1. RSV
13.7.2.4.3.2. Influenza
13.7.2.4.3.3. Streptococcus/Stepthroat
13.7.2.4.3.4. COVID-19 test
13.7.2.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
13.7.2.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
13.7.2.4.3.7. Others
13.7.2.4.4.
Endocrine
(Diabetes)
13.7.2.4.4.1. Rapid blood glucose test
13.7.2.4.4.2. Hemoglobin A1c (HbA1c) test
13.7.2.4.4.3. Ketone
13.7.2.4.5.
Others
13.7.2.5.
Canada
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.2.5.1.
Hospitals
and Clinics
13.7.2.5.2.
Laboratories
13.7.2.5.3.
At-home
testing
13.7.2.5.4.
Others
13.7.3. Mexico
13.7.3.1.
Mexico
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
13.7.3.1.1.
Rapid
Antigen test
13.7.3.1.2.
Rapid
Antibody test
13.7.3.2.
Mexico
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
13.7.3.2.1.
Strips
13.7.3.2.2.
Cassette
13.7.3.2.3.
Card
13.7.3.3.
Mexico
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
13.7.3.3.1.
Professional
tests
13.7.3.3.2.
Over the
counter tests
13.7.3.4.
Mexico
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.4.1.
General
Health
13.7.3.4.1.1. Blood gas analysis (ABG test)
13.7.3.4.1.2. Haemoglobin tests
13.7.3.4.1.3. Lipid profile
13.7.3.4.1.4. Traumatic brain injury (TBI) test
13.7.3.4.1.5. Others
13.7.3.4.2.
STIs /
GYN-OB
13.7.3.4.2.1. HIV
13.7.3.4.2.2. Hepatitis B
13.7.3.4.2.3. Hepatitis C
13.7.3.4.2.4. Pregnancy
13.7.3.4.2.5. Others
13.7.3.4.3.
Infectious
Diseases
13.7.3.4.3.1. RSV
13.7.3.4.3.2. Influenza
13.7.3.4.3.3. Streptococcus/Stepthroat
13.7.3.4.3.4. COVID-19 test
13.7.3.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
13.7.3.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
13.7.3.4.3.7. Others
13.7.3.4.4.
Endocrine
(Diabetes)
13.7.3.4.4.1. Rapid blood glucose test
13.7.3.4.4.2. Hemoglobin A1c (HbA1c) test
13.7.3.4.4.3. Ketone
13.7.3.4.5.
Others
13.7.3.5.
Mexico
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.3.5.1.
Hospitals
and Clinics
13.7.3.5.2.
Laboratories
13.7.3.5.3.
At-home
testing
13.7.3.5.4.
Others
13.7.4. Rest of North America
13.7.4.1.
Rest of
North America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
13.7.4.1.1.
Rapid
Antigen test
13.7.4.1.2.
Rapid
Antibody test
13.7.4.2.
Rest of
North America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
13.7.4.2.1.
Strips
13.7.4.2.2.
Cassette
13.7.4.2.3.
Card
13.7.4.3.
Rest of
North America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product
Type
13.7.4.3.1.
Professional
tests
13.7.4.3.2.
Over the
counter tests
13.7.4.4.
Rest of
North America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
13.7.4.4.1.
General
Health
13.7.4.4.1.1. Blood gas analysis (ABG test)
13.7.4.4.1.2. Haemoglobin tests
13.7.4.4.1.3. Lipid profile
13.7.4.4.1.4. Traumatic brain injury (TBI) test
13.7.4.4.1.5. Others
13.7.4.4.2.
STIs /
GYN-OB
13.7.4.4.2.1. HIV
13.7.4.4.2.2. Hepatitis B
13.7.4.4.2.3. Hepatitis C
13.7.4.4.2.4. Pregnancy
13.7.4.4.2.5. Others
13.7.4.4.3.
Infectious
Diseases
13.7.4.4.3.1. RSV
13.7.4.4.3.2. Influenza
13.7.4.4.3.3. Streptococcus/Stepthroat
13.7.4.4.3.4. COVID-19 test
13.7.4.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
13.7.4.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
13.7.4.4.3.7. Others
13.7.4.4.4.
Endocrine
(Diabetes)
13.7.4.4.4.1. Rapid blood glucose test
13.7.4.4.4.2. Hemoglobin A1c (HbA1c) test
13.7.4.4.4.3. Ketone
13.7.4.4.5.
Others
13.7.4.5.
Rest of
North America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
13.7.4.5.1.
Hospitals
and Clinics
13.7.4.5.2.
Laboratories
13.7.4.5.3.
At-home
testing
13.7.4.5.4.
Others
13.8. Key Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Type
13.8.3. By Format
13.8.4. By Product Type
13.8.5. By
Application
13.8.6. By End Users
14. Europe Rapid Tests Market Analysis and
Forecasts, 2023 - 2031
14.1. Overview
14.1.1. Europe Rapid Tests Market Revenue (US$ Mn)
14.2. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Type
14.2.1. Rapid Antigen test
14.2.2. Rapid Antibody test
14.3. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Format
14.3.1. Strips
14.3.2. Cassette
14.3.3. Card
14.4. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.4.1. Professional tests
14.4.2. Over the counter tests
14.5. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Application
14.5.1. General Health
14.5.1.1.
Blood
gas analysis (ABG test)
14.5.1.2.
Haemoglobin
tests
14.5.1.3.
Lipid
profile
14.5.1.4.
Traumatic
brain injury (TBI) test
14.5.1.5.
Others
14.5.2. STIs / GYN-OB
14.5.2.1.
HIV
14.5.2.2.
Hepatitis
B
14.5.2.3.
Hepatitis
C
14.5.2.4.
Pregnancy
14.5.2.5.
Others
14.5.3. Infectious Diseases
14.5.3.1.
RSV
14.5.3.2.
Influenza
14.5.3.3.
Streptococcus/Stepthroat
14.5.3.4.
COVID-19
test
14.5.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
14.5.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
14.5.3.7.
Others
14.5.4. Endocrine (Diabetes)
14.5.4.1.
Rapid
blood glucose test
14.5.4.2.
Hemoglobin
A1c (HbA1c) test
14.5.4.3.
Ketone
14.5.5. Others
14.6. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.1. Hospitals and Clinics
14.6.2. Laboratories
14.6.3. At-home testing
14.6.4. Others
14.7. Europe Rapid Tests Market Revenue (US$ Mn)
and Forecasts, By Country
14.7.1. France
14.7.1.1.
France
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.1.1.1.
Rapid
Antigen test
14.7.1.1.2.
Rapid
Antibody test
14.7.1.2.
France
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.1.2.1.
Strips
14.7.1.2.2.
Cassette
14.7.1.2.3.
Card
14.7.1.3.
France
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.1.3.1.
Professional
tests
14.7.1.3.2.
Over the
counter tests
14.7.1.4.
France
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.4.1.
General
Health
14.7.1.4.1.1. Blood gas analysis (ABG test)
14.7.1.4.1.2. Haemoglobin tests
14.7.1.4.1.3. Lipid profile
14.7.1.4.1.4. Traumatic brain injury (TBI) test
14.7.1.4.1.5. Others
14.7.1.4.2.
STIs /
GYN-OB
14.7.1.4.2.1. HIV
14.7.1.4.2.2. Hepatitis B
14.7.1.4.2.3. Hepatitis C
14.7.1.4.2.4. Pregnancy
14.7.1.4.2.5. Others
14.7.1.4.3.
Infectious
Diseases
14.7.1.4.3.1. RSV
14.7.1.4.3.2. Influenza
14.7.1.4.3.3. Streptococcus/Stepthroat
14.7.1.4.3.4. COVID-19 test
14.7.1.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.1.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.1.4.3.7. Others
14.7.1.4.4.
Endocrine
(Diabetes)
14.7.1.4.4.1. Rapid blood glucose test
14.7.1.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.1.4.4.3. Ketone
14.7.1.4.5.
Others
14.7.1.5.
France Rapid
Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.1.5.1.
Hospitals
and Clinics
14.7.1.5.2.
Laboratories
14.7.1.5.3.
At-home
testing
14.7.1.5.4.
Others
14.7.2. The UK
14.7.2.1.
The UK
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.2.1.1.
Rapid
Antigen test
14.7.2.1.2.
Rapid
Antibody test
14.7.2.2.
The UK
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.2.2.1.
Strips
14.7.2.2.2.
Cassette
14.7.2.2.3.
Card
14.7.2.3.
The UK
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.2.3.1.
Professional
tests
14.7.2.3.2.
Over the
counter tests
14.7.2.4.
The UK
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.4.1.
General
Health
14.7.2.4.1.1. Blood gas analysis (ABG test)
14.7.2.4.1.2. Haemoglobin tests
14.7.2.4.1.3. Lipid profile
14.7.2.4.1.4. Traumatic brain injury (TBI) test
14.7.2.4.1.5. Others
14.7.2.4.2.
STIs /
GYN-OB
14.7.2.4.2.1. HIV
14.7.2.4.2.2. Hepatitis B
14.7.2.4.2.3. Hepatitis C
14.7.2.4.2.4. Pregnancy
14.7.2.4.2.5. Others
14.7.2.4.3.
Infectious
Diseases
14.7.2.4.3.1. RSV
14.7.2.4.3.2. Influenza
14.7.2.4.3.3. Streptococcus/Stepthroat
14.7.2.4.3.4. COVID-19 test
14.7.2.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.2.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.2.4.3.7. Others
14.7.2.4.4.
Endocrine
(Diabetes)
14.7.2.4.4.1. Rapid blood glucose test
14.7.2.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.2.4.4.3. Ketone
14.7.2.4.5.
Others
14.7.2.5.
The UK
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.2.5.1.
Hospitals
and Clinics
14.7.2.5.2.
Laboratories
14.7.2.5.3.
At-home
testing
14.7.2.5.4.
Others
14.7.3. Spain
14.7.3.1.
Spain
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.3.1.1.
Rapid
Antigen test
14.7.3.1.2.
Rapid
Antibody test
14.7.3.2.
Spain
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.3.2.1.
Strips
14.7.3.2.2.
Cassette
14.7.3.2.3.
Card
14.7.3.3.
Spain
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.3.3.1.
Professional
tests
14.7.3.3.2.
Over the
counter tests
14.7.3.4.
Spain
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.4.1.
General
Health
14.7.3.4.1.1. Blood gas analysis (ABG test)
14.7.3.4.1.2. Haemoglobin tests
14.7.3.4.1.3. Lipid profile
14.7.3.4.1.4. Traumatic brain injury (TBI) test
14.7.3.4.1.5. Others
14.7.3.4.2.
STIs /
GYN-OB
14.7.3.4.2.1. HIV
14.7.3.4.2.2. Hepatitis B
14.7.3.4.2.3. Hepatitis C
14.7.3.4.2.4. Pregnancy
14.7.3.4.2.5. Others
14.7.3.4.3.
Infectious
Diseases
14.7.3.4.3.1. RSV
14.7.3.4.3.2. Influenza
14.7.3.4.3.3. Streptococcus/Stepthroat
14.7.3.4.3.4. COVID-19 test
14.7.3.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.3.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.3.4.3.7. Others
14.7.3.4.4.
Endocrine
(Diabetes)
14.7.3.4.4.1. Rapid blood glucose test
14.7.3.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.3.4.4.3. Ketone
14.7.3.4.5.
Others
14.7.3.5.
Spain
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.3.5.1.
Hospitals
and Clinics
14.7.3.5.2.
Laboratories
14.7.3.5.3.
At-home
testing
14.7.3.5.4.
Others
14.7.4. Germany
14.7.4.1.
Germany
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.4.1.1.
Rapid
Antigen test
14.7.4.1.2.
Rapid
Antibody test
14.7.4.2.
Germany
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.4.2.1.
Strips
14.7.4.2.2.
Cassette
14.7.4.2.3.
Card
14.7.4.3.
Germany
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.4.3.1.
Professional
tests
14.7.4.3.2.
Over the
counter tests
14.7.4.4.
Germany
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.4.1.
General
Health
14.7.4.4.1.1. Blood gas analysis (ABG test)
14.7.4.4.1.2. Haemoglobin tests
14.7.4.4.1.3. Lipid profile
14.7.4.4.1.4. Traumatic brain injury (TBI) test
14.7.4.4.1.5. Others
14.7.4.4.2.
STIs /
GYN-OB
14.7.4.4.2.1. HIV
14.7.4.4.2.2. Hepatitis B
14.7.4.4.2.3. Hepatitis C
14.7.4.4.2.4. Pregnancy
14.7.4.4.2.5. Others
14.7.4.4.3.
Infectious
Diseases
14.7.4.4.3.1. RSV
14.7.4.4.3.2. Influenza
14.7.4.4.3.3. Streptococcus/Stepthroat
14.7.4.4.3.4. COVID-19 test
14.7.4.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.4.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.4.4.3.7. Others
14.7.4.4.4.
Endocrine
(Diabetes)
14.7.4.4.4.1. Rapid blood glucose test
14.7.4.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.4.4.4.3. Ketone
14.7.4.4.5.
Others
14.7.4.5.
Germany
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.4.5.1.
Hospitals
and Clinics
14.7.4.5.2.
Laboratories
14.7.4.5.3.
At-home
testing
14.7.4.5.4.
Others
14.7.5. Italy
14.7.5.1.
Italy
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.5.1.1.
Rapid
Antigen test
14.7.5.1.2.
Rapid
Antibody test
14.7.5.2.
Italy
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.5.2.1.
Strips
14.7.5.2.2.
Cassette
14.7.5.2.3.
Card
14.7.5.3.
Italy
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.5.3.1.
Professional
tests
14.7.5.3.2.
Over the
counter tests
14.7.5.4.
Italy
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.4.1.
General
Health
14.7.5.4.1.1. Blood gas analysis (ABG test)
14.7.5.4.1.2. Haemoglobin tests
14.7.5.4.1.3. Lipid profile
14.7.5.4.1.4. Traumatic brain injury (TBI) test
14.7.5.4.1.5. Others
14.7.5.4.2.
STIs / GYN-OB
14.7.5.4.2.1. HIV
14.7.5.4.2.2. Hepatitis B
14.7.5.4.2.3. Hepatitis C
14.7.5.4.2.4. Pregnancy
14.7.5.4.2.5. Others
14.7.5.4.3.
Infectious
Diseases
14.7.5.4.3.1. RSV
14.7.5.4.3.2. Influenza
14.7.5.4.3.3. Streptococcus/Stepthroat
14.7.5.4.3.4. COVID-19 test
14.7.5.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.5.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.5.4.3.7. Others
14.7.5.4.4.
Endocrine
(Diabetes)
14.7.5.4.4.1. Rapid blood glucose test
14.7.5.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.5.4.4.3. Ketone
14.7.5.4.5.
Others
14.7.5.5.
Italy
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.5.5.1.
Hospitals
and Clinics
14.7.5.5.2.
Laboratories
14.7.5.5.3.
At-home
testing
14.7.5.5.4.
Others
14.7.6. Nordic Countries
14.7.6.1.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.6.1.1.
Rapid
Antigen test
14.7.6.1.2.
Rapid
Antibody test
14.7.6.2.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.6.2.1.
Strips
14.7.6.2.2.
Cassette
14.7.6.2.3.
Card
14.7.6.3.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.6.3.1.
Professional
tests
14.7.6.3.2.
Over the
counter tests
14.7.6.4.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.6.4.1.
General
Health
14.7.6.4.1.1. Blood gas analysis (ABG test)
14.7.6.4.1.2. Haemoglobin tests
14.7.6.4.1.3. Lipid profile
14.7.6.4.1.4. Traumatic brain injury (TBI) test
14.7.6.4.1.5. Others
14.7.6.4.2.
STIs /
GYN-OB
14.7.6.4.2.1. HIV
14.7.6.4.2.2. Hepatitis B
14.7.6.4.2.3. Hepatitis C
14.7.6.4.2.4. Pregnancy
14.7.6.4.2.5. Others
14.7.6.4.3.
Infectious
Diseases
14.7.6.4.3.1. RSV
14.7.6.4.3.2. Influenza
14.7.6.4.3.3. Streptococcus/Stepthroat
14.7.6.4.3.4. COVID-19 test
14.7.6.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.6.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.6.4.3.7. Others
14.7.6.4.4.
Endocrine
(Diabetes)
14.7.6.4.4.1. Rapid blood glucose test
14.7.6.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.6.4.4.3. Ketone
14.7.6.4.5.
Others
14.7.6.5.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.6.5.1.
Hospitals
and Clinics
14.7.6.5.2.
Laboratories
14.7.6.5.3.
At-home
testing
14.7.6.5.4.
Others
14.7.6.6.
Nordic
Countries Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.
Denmark
14.7.6.6.2.
Finland
14.7.6.6.3.
Iceland
14.7.6.6.4.
Sweden
14.7.6.6.5.
Norway
14.7.7. Benelux Union
14.7.7.1.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.7.1.1.
Rapid
Antigen test
14.7.7.1.2.
Rapid
Antibody test
14.7.7.2.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.7.2.1.
Strips
14.7.7.2.2.
Cassette
14.7.7.2.3.
Card
14.7.7.3.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.7.3.1.
Professional
tests
14.7.7.3.2.
Over the
counter tests
14.7.7.4.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.4.1.
General
Health
14.7.7.4.1.1. Blood gas analysis (ABG test)
14.7.7.4.1.2. Haemoglobin tests
14.7.7.4.1.3. Lipid profile
14.7.7.4.1.4. Traumatic brain injury (TBI) test
14.7.7.4.1.5. Others
14.7.7.4.2.
STIs /
GYN-OB
14.7.7.4.2.1. HIV
14.7.7.4.2.2. Hepatitis B
14.7.7.4.2.3. Hepatitis C
14.7.7.4.2.4. Pregnancy
14.7.7.4.2.5. Others
14.7.7.4.3.
Infectious
Diseases
14.7.7.4.3.1. RSV
14.7.7.4.3.2. Influenza
14.7.7.4.3.3. Streptococcus/Stepthroat
14.7.7.4.3.4. COVID-19 test
14.7.7.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.7.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.7.4.3.7. Others
14.7.7.4.4.
Endocrine
(Diabetes)
14.7.7.4.4.1. Rapid blood glucose test
14.7.7.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.7.4.4.3. Ketone
14.7.7.4.5.
Others
14.7.7.5.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.7.5.1.
Hospitals
and Clinics
14.7.7.5.2.
Laboratories
14.7.7.5.3.
At-home
testing
14.7.7.5.4.
Others
14.7.7.6.
Benelux
Union Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.
Belgium
14.7.7.6.2.
The
Netherlands
14.7.7.6.3.
Luxembourg
14.7.8. Rest of Europe
14.7.8.1.
Rest of
Europe Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
14.7.8.1.1.
Rapid
Antigen test
14.7.8.1.2.
Rapid
Antibody test
14.7.8.2.
Rest of
Europe Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
14.7.8.2.1.
Strips
14.7.8.2.2.
Cassette
14.7.8.2.3.
Card
14.7.8.3.
Rest of
Europe Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
14.7.8.3.1.
Professional
tests
14.7.8.3.2.
Over the
counter tests
14.7.8.4.
Rest of
Europe Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.4.1.
General
Health
14.7.8.4.1.1. Blood gas analysis (ABG test)
14.7.8.4.1.2. Haemoglobin tests
14.7.8.4.1.3. Lipid profile
14.7.8.4.1.4. Traumatic brain injury (TBI) test
14.7.8.4.1.5. Others
14.7.8.4.2.
STIs /
GYN-OB
14.7.8.4.2.1. HIV
14.7.8.4.2.2. Hepatitis B
14.7.8.4.2.3. Hepatitis C
14.7.8.4.2.4. Pregnancy
14.7.8.4.2.5. Others
14.7.8.4.3.
Infectious
Diseases
14.7.8.4.3.1. RSV
14.7.8.4.3.2. Influenza
14.7.8.4.3.3. Streptococcus/Stepthroat
14.7.8.4.3.4. COVID-19 test
14.7.8.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
14.7.8.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
14.7.8.4.3.7. Others
14.7.8.4.4.
Endocrine
(Diabetes)
14.7.8.4.4.1. Rapid blood glucose test
14.7.8.4.4.2. Hemoglobin A1c (HbA1c) test
14.7.8.4.4.3. Ketone
14.7.8.4.5.
Others
14.7.8.5.
Rest of
Europe Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.8.5.1.
Hospitals
and Clinics
14.7.8.5.2.
Laboratories
14.7.8.5.3.
At-home
testing
14.7.8.5.4.
Others
14.8. Key Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Type
14.8.3. By Format
14.8.4. By Product Type
14.8.5. By
Application
14.8.6. By End Users
15. Asia Pacific Rapid Tests Market Analysis and
Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Asia Pacific Rapid Tests Market Revenue (US$
Mn)
15.2. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Type
15.2.1. Rapid Antigen test
15.2.2. Rapid Antibody test
15.3. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Format
15.3.1. Strips
15.3.2. Cassette
15.3.3. Card
15.4. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Product Type
15.4.1. Professional tests
15.4.2. Over the counter tests
15.5. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Application
15.5.1. General Health
15.5.1.1.
Blood
gas analysis (ABG test)
15.5.1.2.
Haemoglobin
tests
15.5.1.3.
Lipid
profile
15.5.1.4.
Traumatic
brain injury (TBI) test
15.5.1.5.
Others
15.5.2. STIs / GYN-OB
15.5.2.1.
HIV
15.5.2.2.
Hepatitis
B
15.5.2.3.
Hepatitis
C
15.5.2.4.
Pregnancy
15.5.2.5.
Others
15.5.3. Infectious Diseases
15.5.3.1.
RSV
15.5.3.2.
Influenza
15.5.3.3.
Streptococcus/Stepthroat
15.5.3.4.
COVID-19
test
15.5.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
15.5.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
15.5.3.7.
Others
15.5.4. Endocrine (Diabetes)
15.5.4.1.
Rapid
blood glucose test
15.5.4.2.
Hemoglobin
A1c (HbA1c) test
15.5.4.3.
Ketone
15.5.5. Others
15.6. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By End Users
15.6.1. Hospitals and Clinics
15.6.2. Laboratories
15.6.3. At-home testing
15.6.4. Others
15.7. Asia Pacific Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1.
China
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.1.1.1.
Rapid
Antigen test
15.7.1.1.2.
Rapid
Antibody test
15.7.1.2.
China
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.1.2.1.
Strips
15.7.1.2.2.
Cassette
15.7.1.2.3.
Card
15.7.1.3.
China
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.1.3.1.
Professional
tests
15.7.1.3.2.
Over the
counter tests
15.7.1.4.
China
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.4.1.
General
Health
15.7.1.4.1.1. Blood gas analysis (ABG test)
15.7.1.4.1.2. Haemoglobin tests
15.7.1.4.1.3. Lipid profile
15.7.1.4.1.4. Traumatic brain injury (TBI) test
15.7.1.4.1.5. Others
15.7.1.4.2.
STIs /
GYN-OB
15.7.1.4.2.1. HIV
15.7.1.4.2.2. Hepatitis B
15.7.1.4.2.3. Hepatitis C
15.7.1.4.2.4. Pregnancy
15.7.1.4.2.5. Others
15.7.1.4.3.
Infectious
Diseases
15.7.1.4.3.1. RSV
15.7.1.4.3.2. Influenza
15.7.1.4.3.3. Streptococcus/Stepthroat
15.7.1.4.3.4. COVID-19 test
15.7.1.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
15.7.1.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.1.4.3.7. Others
15.7.1.4.4.
Endocrine
(Diabetes)
15.7.1.4.4.1. Rapid blood glucose test
15.7.1.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.1.4.4.3. Ketone
15.7.1.4.5.
Others
15.7.1.5.
China
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.1.5.1.
Hospitals
and Clinics
15.7.1.5.2.
Laboratories
15.7.1.5.3.
At-home
testing
15.7.1.5.4.
Others
15.7.2. Japan
15.7.2.1.
Japan
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.2.1.1.
Rapid
Antigen test
15.7.2.1.2.
Rapid
Antibody test
15.7.2.2.
Japan
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.2.2.1.
Strips
15.7.2.2.2.
Cassette
15.7.2.2.3.
Card
15.7.2.3.
Japan
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.2.3.1.
Professional
tests
15.7.2.3.2.
Over the
counter tests
15.7.2.4.
Japan
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.4.1.
General
Health
15.7.2.4.1.1. Blood gas analysis (ABG test)
15.7.2.4.1.2. Haemoglobin tests
15.7.2.4.1.3. Lipid profile
15.7.2.4.1.4. Traumatic brain injury (TBI) test
15.7.2.4.1.5. Others
15.7.2.4.2.
STIs /
GYN-OB
15.7.2.4.2.1. HIV
15.7.2.4.2.2. Hepatitis B
15.7.2.4.2.3. Hepatitis C
15.7.2.4.2.4. Pregnancy
15.7.2.4.2.5. Others
15.7.2.4.3.
Infectious
Diseases
15.7.2.4.3.1. RSV
15.7.2.4.3.2. Influenza
15.7.2.4.3.3. Streptococcus/Stepthroat
15.7.2.4.3.4. COVID-19 test
15.7.2.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
15.7.2.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.2.4.3.7. Others
15.7.2.4.4.
Endocrine
(Diabetes)
15.7.2.4.4.1. Rapid blood glucose test
15.7.2.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.2.4.4.3. Ketone
15.7.2.4.5.
Others
15.7.2.5.
Japan
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.2.5.1.
Hospitals
and Clinics
15.7.2.5.2.
Laboratories
15.7.2.5.3.
At-home
testing
15.7.2.5.4.
Others
15.7.3. India
15.7.3.1.
India
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.3.1.1.
Rapid
Antigen test
15.7.3.1.2.
Rapid
Antibody test
15.7.3.2.
India
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.3.2.1.
Strips
15.7.3.2.2.
Cassette
15.7.3.2.3.
Card
15.7.3.3.
India
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.3.3.1.
Professional
tests
15.7.3.3.2.
Over the
counter tests
15.7.3.4.
India
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.4.1.
General
Health
15.7.3.4.1.1. Blood gas analysis (ABG test)
15.7.3.4.1.2. Haemoglobin tests
15.7.3.4.1.3. Lipid profile
15.7.3.4.1.4. Traumatic brain injury (TBI) test
15.7.3.4.1.5. Others
15.7.3.4.2.
STIs /
GYN-OB
15.7.3.4.2.1. HIV
15.7.3.4.2.2. Hepatitis B
15.7.3.4.2.3. Hepatitis C
15.7.3.4.2.4. Pregnancy
15.7.3.4.2.5. Others
15.7.3.4.3.
Infectious
Diseases
15.7.3.4.3.1. RSV
15.7.3.4.3.2. Influenza
15.7.3.4.3.3. Streptococcus/Stepthroat
15.7.3.4.3.4. COVID-19 test
15.7.3.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
15.7.3.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.3.4.3.7. Others
15.7.3.4.4.
Endocrine
(Diabetes)
15.7.3.4.4.1. Rapid blood glucose test
15.7.3.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.3.4.4.3. Ketone
15.7.3.4.5.
Others
15.7.3.5.
India
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.3.5.1.
Hospitals
and Clinics
15.7.3.5.2.
Laboratories
15.7.3.5.3.
At-home
testing
15.7.3.5.4.
Others
15.7.4. New Zealand
15.7.4.1.
New
Zealand Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.4.1.1.
Rapid
Antigen test
15.7.4.1.2.
Rapid
Antibody test
15.7.4.2.
New
Zealand Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.4.2.1.
Strips
15.7.4.2.2.
Cassette
15.7.4.2.3.
Card
15.7.4.3.
New
Zealand Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.4.3.1.
Professional
tests
15.7.4.3.2.
Over the
counter tests
15.7.4.4.
New
Zealand Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.4.1.
General Health
15.7.4.4.1.1. Blood gas analysis (ABG test)
15.7.4.4.1.2. Haemoglobin tests
15.7.4.4.1.3. Lipid profile
15.7.4.4.1.4. Traumatic brain injury (TBI) test
15.7.4.4.1.5. Others
15.7.4.4.2.
STIs /
GYN-OB
15.7.4.4.2.1. HIV
15.7.4.4.2.2. Hepatitis B
15.7.4.4.2.3. Hepatitis C
15.7.4.4.2.4. Pregnancy
15.7.4.4.2.5. Others
15.7.4.4.3.
Infectious
Diseases
15.7.4.4.3.1. RSV
15.7.4.4.3.2. Influenza
15.7.4.4.3.3. Streptococcus/Stepthroat
15.7.4.4.3.4. COVID-19 test
15.7.4.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
15.7.4.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.4.4.3.7. Others
15.7.4.4.4.
Endocrine
(Diabetes)
15.7.4.4.4.1. Rapid blood glucose test
15.7.4.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.4.4.4.3. Ketone
15.7.4.4.5.
Others
15.7.4.5.
New
Zealand Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.4.5.1.
Hospitals
and Clinics
15.7.4.5.2.
Laboratories
15.7.4.5.3.
At-home
testing
15.7.4.5.4.
Others
15.7.5. Australia
15.7.5.1.
Australia
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.5.1.1.
Rapid
Antigen test
15.7.5.1.2.
Rapid
Antibody test
15.7.5.2.
Australia
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.5.2.1.
Strips
15.7.5.2.2.
Cassette
15.7.5.2.3.
Card
15.7.5.3.
Australia
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.5.3.1.
Professional
tests
15.7.5.3.2.
Over the
counter tests
15.7.5.4.
Australia
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.4.1.
General
Health
15.7.5.4.1.1. Blood gas analysis (ABG test)
15.7.5.4.1.2. Haemoglobin tests
15.7.5.4.1.3. Lipid profile
15.7.5.4.1.4. Traumatic brain injury (TBI) test
15.7.5.4.1.5. Others
15.7.5.4.2.
STIs /
GYN-OB
15.7.5.4.2.1. HIV
15.7.5.4.2.2. Hepatitis B
15.7.5.4.2.3. Hepatitis C
15.7.5.4.2.4. Pregnancy
15.7.5.4.2.5. Others
15.7.5.4.3.
Infectious
Diseases
15.7.5.4.3.1. RSV
15.7.5.4.3.2. Influenza
15.7.5.4.3.3. Streptococcus/Stepthroat
15.7.5.4.3.4. COVID-19 test
15.7.5.4.3.5. C-reactive protein (CRP) test(inflammation/infection)
15.7.5.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.5.4.3.7. Others
15.7.5.4.4.
Endocrine
(Diabetes)
15.7.5.4.4.1. Rapid blood glucose test
15.7.5.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.5.4.4.3. Ketone
15.7.5.4.5.
Others
15.7.5.5.
Australia
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.5.5.1.
Hospitals
and Clinics
15.7.5.5.2.
Laboratories
15.7.5.5.3.
At-home
testing
15.7.5.5.4.
Others
15.7.6. South Korea
15.7.6.1.
South
Korea Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.6.1.1.
Rapid
Antigen test
15.7.6.1.2.
Rapid
Antibody test
15.7.6.2.
South
Korea Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.6.2.1.
Strips
15.7.6.2.2.
Cassette
15.7.6.2.3.
Card
15.7.6.3.
South
Korea Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.6.3.1.
Professional
tests
15.7.6.3.2.
Over the
counter tests
15.7.6.4.
South
Korea Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.4.1.
General
Health
15.7.6.4.1.1. Blood gas analysis (ABG test)
15.7.6.4.1.2. Haemoglobin tests
15.7.6.4.1.3. Lipid profile
15.7.6.4.1.4. Traumatic brain injury (TBI) test
15.7.6.4.1.5. Others
15.7.6.4.2.
STIs /
GYN-OB
15.7.6.4.2.1. HIV
15.7.6.4.2.2. Hepatitis B
15.7.6.4.2.3. Hepatitis C
15.7.6.4.2.4. Pregnancy
15.7.6.4.2.5. Others
15.7.6.4.3.
Infectious
Diseases
15.7.6.4.3.1. RSV
15.7.6.4.3.2. Influenza
15.7.6.4.3.3. Streptococcus/Stepthroat
15.7.6.4.3.4. COVID-19 test
15.7.6.4.3.5. C-reactive protein (CRP) test(inflammation/infection)
15.7.6.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.6.4.3.7. Others
15.7.6.4.4.
Endocrine
(Diabetes)
15.7.6.4.4.1. Rapid blood glucose test
15.7.6.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.6.4.4.3. Ketone
15.7.6.4.5.
Others
15.7.6.5.
South
Korea Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.6.5.1.
Hospitals
and Clinics
15.7.6.5.2.
Laboratories
15.7.6.5.3.
At-home
testing
15.7.6.5.4.
Others
15.7.7. Southeast Asia
15.7.7.1.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.7.1.1.
Rapid
Antigen test
15.7.7.1.2.
Rapid
Antibody test
15.7.7.2.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.7.2.1.
Strips
15.7.7.2.2.
Cassette
15.7.7.2.3.
Card
15.7.7.3.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.7.3.1.
Professional
tests
15.7.7.3.2.
Over the
counter tests
15.7.7.4.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.4.1.
General
Health
15.7.7.4.1.1. Blood gas analysis (ABG test)
15.7.7.4.1.2. Haemoglobin tests
15.7.7.4.1.3. Lipid profile
15.7.7.4.1.4. Traumatic brain injury (TBI) test
15.7.7.4.1.5. Others
15.7.7.4.2.
STIs /
GYN-OB
15.7.7.4.2.1. HIV
15.7.7.4.2.2. Hepatitis B
15.7.7.4.2.3. Hepatitis C
15.7.7.4.2.4. Pregnancy
15.7.7.4.2.5. Others
15.7.7.4.3.
Infectious
Diseases
15.7.7.4.3.1. RSV
15.7.7.4.3.2. Influenza
15.7.7.4.3.3. Streptococcus/Stepthroat
15.7.7.4.3.4. COVID-19 test
15.7.7.4.3.5. C-reactive protein (CRP) test(inflammation/infection)
15.7.7.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.7.4.3.7. Others
15.7.7.4.4.
Endocrine
(Diabetes)
15.7.7.4.4.1. Rapid blood glucose test
15.7.7.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.7.4.4.3. Ketone
15.7.7.4.5.
Others
15.7.7.5.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.7.5.1.
Hospitals
and Clinics
15.7.7.5.2.
Laboratories
15.7.7.5.3.
At-home
testing
15.7.7.5.4.
Others
15.7.7.6.
Southeast
Asia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.
Indonesia
15.7.7.6.2.
Thailand
15.7.7.6.3.
Malaysia
15.7.7.6.4.
Singapore
15.7.7.6.5.
Rest of
Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1.
Rest of
Asia Pacific Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
15.7.8.1.1.
Rapid
Antigen test
15.7.8.1.2.
Rapid
Antibody test
15.7.8.2.
Rest of
Asia Pacific Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
15.7.8.2.1.
Strips
15.7.8.2.2.
Cassette
15.7.8.2.3.
Card
15.7.8.3.
Rest of
Asia Pacific Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
15.7.8.3.1.
Professional
tests
15.7.8.3.2.
Over the
counter tests
15.7.8.4.
Rest of
Asia Pacific Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
15.7.8.4.1.
General
Health
15.7.8.4.1.1. Blood gas analysis (ABG test)
15.7.8.4.1.2. Haemoglobin tests
15.7.8.4.1.3. Lipid profile
15.7.8.4.1.4. Traumatic brain injury (TBI) test
15.7.8.4.1.5. Others
15.7.8.4.2.
STIs /
GYN-OB
15.7.8.4.2.1. HIV
15.7.8.4.2.2. Hepatitis B
15.7.8.4.2.3. Hepatitis C
15.7.8.4.2.4. Pregnancy
15.7.8.4.2.5. Others
15.7.8.4.3.
Infectious
Diseases
15.7.8.4.3.1. RSV
15.7.8.4.3.2. Influenza
15.7.8.4.3.3. Streptococcus/Stepthroat
15.7.8.4.3.4. COVID-19 test
15.7.8.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
15.7.8.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
15.7.8.4.3.7. Others
15.7.8.4.4.
Endocrine
(Diabetes)
15.7.8.4.4.1. Rapid blood glucose test
15.7.8.4.4.2. Hemoglobin A1c (HbA1c) test
15.7.8.4.4.3. Ketone
15.7.8.4.5.
Others
15.7.8.5.
Rest of
Asia Pacific Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.8.5.1.
Hospitals
and Clinics
15.7.8.5.2.
Laboratories
15.7.8.5.3.
At-home
testing
15.7.8.5.4.
Others
15.8. Key Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Type
15.8.3. By Format
15.8.4. By Product Type
15.8.5. By
Application
15.8.6. By End Users
16. Middle East and Africa Rapid Tests Market
Analysis and Forecasts, 2023 - 2031
16.1. Overview
16.1.1. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn)
16.2. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn) and Forecasts, By Type
16.2.1. Rapid Antigen test
16.2.2. Rapid Antibody test
16.3. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn) and Forecasts, By Format
16.3.1. Strips
16.3.2. Cassette
16.3.3. Card
16.4. Middle East and Africa Rapid Tests Market Revenue
(US$ Mn) and Forecasts, By Product Type
16.4.1. Professional tests
16.4.2. Over the counter tests
16.5. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn) and Forecasts, By
Application
16.5.1. General Health
16.5.1.1.
Blood
gas analysis (ABG test)
16.5.1.2.
Haemoglobin
tests
16.5.1.3.
Lipid
profile
16.5.1.4.
Traumatic
brain injury (TBI) test
16.5.1.5.
Others
16.5.2. STIs / GYN-OB
16.5.2.1.
HIV
16.5.2.2.
Hepatitis
B
16.5.2.3.
Hepatitis
C
16.5.2.4.
Pregnancy
16.5.2.5.
Others
16.5.3. Infectious Diseases
16.5.3.1.
RSV
16.5.3.2.
Influenza
16.5.3.3.
Streptococcus/Stepthroat
16.5.3.4.
COVID-19
test
16.5.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
16.5.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
16.5.3.7.
Others
16.5.4. Endocrine (Diabetes)
16.5.4.1.
Rapid
blood glucose test
16.5.4.2.
Hemoglobin
A1c (HbA1c) test
16.5.4.3.
Ketone
16.5.5. Others
16.6. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn) and Forecasts, By End Users
16.6.1. Hospitals and Clinics
16.6.2. Laboratories
16.6.3. At-home testing
16.6.4. Others
16.7. Middle East and Africa Rapid Tests Market
Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1.
Saudi
Arabia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
16.7.1.1.1.
Rapid
Antigen test
16.7.1.1.2.
Rapid
Antibody test
16.7.1.2.
Saudi
Arabia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
16.7.1.2.1.
Strips
16.7.1.2.2.
Cassette
16.7.1.2.3.
Card
16.7.1.3.
Saudi
Arabia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
16.7.1.3.1.
Professional
tests
16.7.1.3.2.
Over the
counter tests
16.7.1.4.
Saudi
Arabia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.4.1.
General
Health
16.7.1.4.1.1. Blood gas analysis (ABG test)
16.7.1.4.1.2. Haemoglobin tests
16.7.1.4.1.3. Lipid profile
16.7.1.4.1.4. Traumatic brain injury (TBI) test
16.7.1.4.1.5. Others
16.7.1.4.2.
STIs /
GYN-OB
16.7.1.4.2.1. HIV
16.7.1.4.2.2. Hepatitis B
16.7.1.4.2.3. Hepatitis C
16.7.1.4.2.4. Pregnancy
16.7.1.4.2.5. Others
16.7.1.4.3.
Infectious
Diseases
16.7.1.4.3.1. RSV
16.7.1.4.3.2. Influenza
16.7.1.4.3.3. Streptococcus/Stepthroat
16.7.1.4.3.4. COVID-19 test
16.7.1.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.1.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
16.7.1.4.3.7. Others
16.7.1.4.4.
Endocrine
(Diabetes)
16.7.1.4.4.1. Rapid blood glucose test
16.7.1.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.1.4.4.3. Ketone
16.7.1.4.5.
Others
16.7.1.5.
Saudi
Arabia Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.1.5.1.
Hospitals
and Clinics
16.7.1.5.2.
Laboratories
16.7.1.5.3.
At-home
testing
16.7.1.5.4.
Others
16.7.2. UAE
16.7.2.1.
UAE
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
16.7.2.1.1.
Rapid
Antigen test
16.7.2.1.2.
Rapid
Antibody test
16.7.2.2.
UAE
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
16.7.2.2.1.
Strips
16.7.2.2.2.
Cassette
16.7.2.2.3.
Card
16.7.2.3.
UAE
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
16.7.2.3.1.
Professional
tests
16.7.2.3.2.
Over the
counter tests
16.7.2.4.
UAE
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.4.1.
General
Health
16.7.2.4.1.1. Blood gas analysis (ABG test)
16.7.2.4.1.2. Haemoglobin tests
16.7.2.4.1.3. Lipid profile
16.7.2.4.1.4. Traumatic brain injury (TBI) test
16.7.2.4.1.5. Others
16.7.2.4.2.
STIs /
GYN-OB
16.7.2.4.2.1. HIV
16.7.2.4.2.2. Hepatitis B
16.7.2.4.2.3. Hepatitis C
16.7.2.4.2.4. Pregnancy
16.7.2.4.2.5. Others
16.7.2.4.3.
Infectious
Diseases
16.7.2.4.3.1. RSV
16.7.2.4.3.2. Influenza
16.7.2.4.3.3. Streptococcus/Stepthroat
16.7.2.4.3.4. COVID-19 test
16.7.2.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.2.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
16.7.2.4.3.7. Others
16.7.2.4.4.
Endocrine
(Diabetes)
16.7.2.4.4.1. Rapid blood glucose test
16.7.2.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.2.4.4.3. Ketone
16.7.2.4.5.
Others
16.7.2.5.
UAE
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.2.5.1.
Hospitals
and Clinics
16.7.2.5.2.
Laboratories
16.7.2.5.3.
At-home
testing
16.7.2.5.4.
Others
16.7.3. Egypt
16.7.3.1.
Egypt
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
16.7.3.1.1.
Rapid
Antigen test
16.7.3.1.2.
Rapid
Antibody test
16.7.3.2.
Egypt
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
16.7.3.2.1.
Strips
16.7.3.2.2.
Cassette
16.7.3.2.3.
Card
16.7.3.3.
Egypt
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
16.7.3.3.1.
Professional
tests
16.7.3.3.2.
Over the
counter tests
16.7.3.4.
Egypt
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.4.1.
General
Health
16.7.3.4.1.1. Blood gas analysis (ABG test)
16.7.3.4.1.2. Haemoglobin tests
16.7.3.4.1.3. Lipid profile
16.7.3.4.1.4. Traumatic brain injury (TBI) test
16.7.3.4.1.5. Others
16.7.3.4.2.
STIs /
GYN-OB
16.7.3.4.2.1. HIV
16.7.3.4.2.2. Hepatitis B
16.7.3.4.2.3. Hepatitis C
16.7.3.4.2.4. Pregnancy
16.7.3.4.2.5. Others
16.7.3.4.3.
Infectious
Diseases
16.7.3.4.3.1. RSV
16.7.3.4.3.2. Influenza
16.7.3.4.3.3. Streptococcus/Stepthroat
16.7.3.4.3.4. COVID-19 test
16.7.3.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.3.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial infections)
16.7.3.4.3.7. Others
16.7.3.4.4.
Endocrine
(Diabetes)
16.7.3.4.4.1. Rapid blood glucose test
16.7.3.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.3.4.4.3. Ketone
16.7.3.4.5.
Others
16.7.3.5.
Egypt
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.3.5.1.
Hospitals
and Clinics
16.7.3.5.2.
Laboratories
16.7.3.5.3.
At-home
testing
16.7.3.5.4.
Others
16.7.4. Kuwait
16.7.4.1.
Kuwait
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
16.7.4.1.1.
Rapid
Antigen test
16.7.4.1.2.
Rapid
Antibody test
16.7.4.2.
Kuwait
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
16.7.4.2.1.
Strips
16.7.4.2.2.
Cassette
16.7.4.2.3.
Card
16.7.4.3.
Kuwait
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
16.7.4.3.1.
Professional
tests
16.7.4.3.2.
Over the
counter tests
16.7.4.4.
Kuwait
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.4.1.
General
Health
16.7.4.4.1.1. Blood gas analysis (ABG test)
16.7.4.4.1.2. Haemoglobin tests
16.7.4.4.1.3. Lipid profile
16.7.4.4.1.4. Traumatic brain injury (TBI) test
16.7.4.4.1.5. Others
16.7.4.4.2.
STIs /
GYN-OB
16.7.4.4.2.1. HIV
16.7.4.4.2.2. Hepatitis B
16.7.4.4.2.3. Hepatitis C
16.7.4.4.2.4. Pregnancy
16.7.4.4.2.5. Others
16.7.4.4.3.
Infectious
Diseases
16.7.4.4.3.1. RSV
16.7.4.4.3.2. Influenza
16.7.4.4.3.3. Streptococcus/Stepthroat
16.7.4.4.3.4. COVID-19 test
16.7.4.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.4.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
16.7.4.4.3.7. Others
16.7.4.4.4.
Endocrine
(Diabetes)
16.7.4.4.4.1. Rapid blood glucose test
16.7.4.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.4.4.4.3. Ketone
16.7.4.4.5.
Others
16.7.4.5.
Kuwait
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.4.5.1.
Hospitals
and Clinics
16.7.4.5.2.
Laboratories
16.7.4.5.3.
At-home
testing
16.7.4.5.4.
Others
16.7.5. South Africa
16.7.5.1.
South
Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
16.7.5.1.1.
Rapid
Antigen test
16.7.5.1.2.
Rapid
Antibody test
16.7.5.2.
South
Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
16.7.5.2.1.
Strips
16.7.5.2.2.
Cassette
16.7.5.2.3.
Card
16.7.5.3.
South
Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
16.7.5.3.1.
Professional
tests
16.7.5.3.2.
Over the
counter tests
16.7.5.4.
South
Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.4.1.
General
Health
16.7.5.4.1.1. Blood gas analysis (ABG test)
16.7.5.4.1.2. Haemoglobin tests
16.7.5.4.1.3. Lipid profile
16.7.5.4.1.4. Traumatic brain injury (TBI) test
16.7.5.4.1.5. Others
16.7.5.4.2.
STIs /
GYN-OB
16.7.5.4.2.1. HIV
16.7.5.4.2.2. Hepatitis B
16.7.5.4.2.3. Hepatitis C
16.7.5.4.2.4. Pregnancy
16.7.5.4.2.5. Others
16.7.5.4.3.
Infectious
Diseases
16.7.5.4.3.1. RSV
16.7.5.4.3.2. Influenza
16.7.5.4.3.3. Streptococcus/Stepthroat
16.7.5.4.3.4. COVID-19 test
16.7.5.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.5.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
16.7.5.4.3.7. Others
16.7.5.4.4.
Endocrine
(Diabetes)
16.7.5.4.4.1. Rapid blood glucose test
16.7.5.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.5.4.4.3. Ketone
16.7.5.4.5.
Others
16.7.5.5.
South
Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.5.5.1.
Hospitals
and Clinics
16.7.5.5.2.
Laboratories
16.7.5.5.3.
At-home
testing
16.7.5.5.4.
Others
16.7.6. Rest of Middle East & Africa
16.7.6.1.
Rest of
Middle East & Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By
Type
16.7.6.1.1.
Rapid
Antigen test
16.7.6.1.2.
Rapid
Antibody test
16.7.6.2.
Rest of
Middle East & Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By
Format
16.7.6.2.1.
Strips
16.7.6.2.2.
Cassette
16.7.6.2.3.
Card
16.7.6.3.
Rest of
Middle East & Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.7.6.3.1.
Professional
tests
16.7.6.3.2.
Over the
counter tests
16.7.6.4.
Rest of
Middle East & Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.6.4.1.
General
Health
16.7.6.4.1.1. Blood gas analysis (ABG test)
16.7.6.4.1.2. Haemoglobin tests
16.7.6.4.1.3. Lipid profile
16.7.6.4.1.4. Traumatic brain injury (TBI) test
16.7.6.4.1.5. Others
16.7.6.4.2.
STIs /
GYN-OB
16.7.6.4.2.1. HIV
16.7.6.4.2.2. Hepatitis B
16.7.6.4.2.3. Hepatitis C
16.7.6.4.2.4. Pregnancy
16.7.6.4.2.5. Others
16.7.6.4.3.
Infectious
Diseases
16.7.6.4.3.1. RSV
16.7.6.4.3.2. Influenza
16.7.6.4.3.3. Streptococcus/Stepthroat
16.7.6.4.3.4. COVID-19 test
16.7.6.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
16.7.6.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
16.7.6.4.3.7. Others
16.7.6.4.4.
Endocrine
(Diabetes)
16.7.6.4.4.1. Rapid blood glucose test
16.7.6.4.4.2. Hemoglobin A1c (HbA1c) test
16.7.6.4.4.3. Ketone
16.7.6.4.5.
Others
16.7.6.5.
Rest of
Middle East & Africa Rapid Tests Market Revenue (US$ Mn) and Forecasts, By
End Users
16.7.6.5.1.
Hospitals
and Clinics
16.7.6.5.2.
Laboratories
16.7.6.5.3.
At-home
testing
16.7.6.5.4.
Others
16.8. Key Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Type
16.8.3. By Format
16.8.4. By Product Type
16.8.5. By
Application
16.8.6. By End Users
17. Latin America Rapid Tests Market Analysis
and Forecasts, 2023 - 2031
17.1. Overview
17.1.1. Latin America Rapid Tests Market Revenue (US$
Mn)
17.2. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Type
17.2.1. Rapid Antigen test
17.2.2. Rapid Antibody test
17.3. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Format
17.3.1. Strips
17.3.2. Cassette
17.3.3. Card
17.4. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Product Type
17.4.1. Professional tests
17.4.2. Over the counter tests
17.5. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Application
17.5.1. General Health
17.5.1.1.
Blood
gas analysis (ABG test)
17.5.1.2.
Haemoglobin
tests
17.5.1.3.
Lipid
profile
17.5.1.4.
Traumatic
brain injury (TBI) test
17.5.1.5.
Others
17.5.2. STIs / GYN-OB
17.5.2.1.
HIV
17.5.2.2.
Hepatitis
B
17.5.2.3.
Hepatitis
C
17.5.2.4.
Pregnancy
17.5.2.5.
Others
17.5.3. Infectious Diseases
17.5.3.1.
RSV
17.5.3.2.
Influenza
17.5.3.3.
Streptococcus/Stepthroat
17.5.3.4.
COVID-19
test
17.5.3.5.
C-reactive
protein (CRP) test(inflammation/infection)
17.5.3.6.
Procalcitonin
(PCT) test (sepsis/bacterial infections)
17.5.3.7.
Others
17.5.4. Endocrine (Diabetes)
17.5.4.1.
Rapid
blood glucose test
17.5.4.2.
Hemoglobin
A1c (HbA1c) test
17.5.4.3.
Ketone
17.5.5. Others
17.6. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By End Users
17.6.1. Hospitals and Clinics
17.6.2. Laboratories
17.6.3. At-home testing
17.6.4. Others
17.7. Latin America Rapid Tests Market Revenue (US$
Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1.
Brazil
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
17.7.1.1.1.
Rapid
Antigen test
17.7.1.1.2.
Rapid
Antibody test
17.7.1.2.
Brazil
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
17.7.1.2.1.
Strips
17.7.1.2.2.
Cassette
17.7.1.2.3.
Card
17.7.1.3.
Brazil
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
17.7.1.3.1.
Professional
tests
17.7.1.3.2.
Over the
counter tests
17.7.1.4.
Brazil
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.4.1.
General
Health
17.7.1.4.1.1. Blood gas analysis (ABG test)
17.7.1.4.1.2. Haemoglobin tests
17.7.1.4.1.3. Lipid profile
17.7.1.4.1.4. Traumatic brain injury (TBI) test
17.7.1.4.1.5. Others
17.7.1.4.2.
STIs /
GYN-OB
17.7.1.4.2.1. HIV
17.7.1.4.2.2. Hepatitis B
17.7.1.4.2.3. Hepatitis C
17.7.1.4.2.4. Pregnancy
17.7.1.4.2.5. Others
17.7.1.4.3.
Infectious
Diseases
17.7.1.4.3.1. RSV
17.7.1.4.3.2. Influenza
17.7.1.4.3.3. Streptococcus/Stepthroat
17.7.1.4.3.4. COVID-19 test
17.7.1.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
17.7.1.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
17.7.1.4.3.7. Others
17.7.1.4.4.
Endocrine
(Diabetes)
17.7.1.4.4.1. Rapid blood glucose test
17.7.1.4.4.2. Hemoglobin A1c (HbA1c) test
17.7.1.4.4.3. Ketone
17.7.1.4.5.
Others
17.7.1.5.
Brazil
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.1.5.1.
Hospitals
and Clinics
17.7.1.5.2.
Laboratories
17.7.1.5.3.
At-home
testing
17.7.1.5.4.
Others
17.7.2. Argentina
17.7.2.1.
Argentina
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
17.7.2.1.1.
Rapid
Antigen test
17.7.2.1.2.
Rapid
Antibody test
17.7.2.2.
Argentina
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
17.7.2.2.1.
Strips
17.7.2.2.2.
Cassette
17.7.2.2.3.
Card
17.7.2.3.
Argentina
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product Type
17.7.2.3.1.
Professional
tests
17.7.2.3.2.
Over the
counter tests
17.7.2.4.
Argentina
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.4.1.
General
Health
17.7.2.4.1.1. Blood gas analysis (ABG test)
17.7.2.4.1.2. Haemoglobin tests
17.7.2.4.1.3. Lipid profile
17.7.2.4.1.4. Traumatic brain injury (TBI) test
17.7.2.4.1.5. Others
17.7.2.4.2.
STIs /
GYN-OB
17.7.2.4.2.1. HIV
17.7.2.4.2.2. Hepatitis B
17.7.2.4.2.3. Hepatitis C
17.7.2.4.2.4. Pregnancy
17.7.2.4.2.5. Others
17.7.2.4.3.
Infectious
Diseases
17.7.2.4.3.1. RSV
17.7.2.4.3.2. Influenza
17.7.2.4.3.3. Streptococcus/Stepthroat
17.7.2.4.3.4. COVID-19 test
17.7.2.4.3.5. C-reactive protein (CRP)
test(inflammation/infection)
17.7.2.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
17.7.2.4.3.7. Others
17.7.2.4.4.
Endocrine
(Diabetes)
17.7.2.4.4.1. Rapid blood glucose test
17.7.2.4.4.2. Hemoglobin A1c (HbA1c) test
17.7.2.4.4.3. Ketone
17.7.2.4.5.
Others
17.7.2.5.
Argentina
Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.2.5.1.
Hospitals
and Clinics
17.7.2.5.2.
Laboratories
17.7.2.5.3.
At-home
testing
17.7.2.5.4.
Others
17.7.3. Rest of Latin America
17.7.3.1.
Rest of
Latin America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Type
17.7.3.1.1.
Rapid
Antigen test
17.7.3.1.2.
Rapid
Antibody test
17.7.3.2.
Rest of
Latin America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Format
17.7.3.2.1.
Strips
17.7.3.2.2.
Cassette
17.7.3.2.3.
Card
17.7.3.3.
Rest of
Latin America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Product
Type
17.7.3.3.1.
Professional
tests
17.7.3.3.2.
Over the
counter tests
17.7.3.4.
Rest of
Latin America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By Application
17.7.3.4.1.
General
Health
17.7.3.4.1.1. Blood gas analysis (ABG test)
17.7.3.4.1.2. Haemoglobin tests
17.7.3.4.1.3. Lipid profile
17.7.3.4.1.4. Traumatic brain injury (TBI) test
17.7.3.4.1.5. Others
17.7.3.4.2.
STIs /
GYN-OB
17.7.3.4.2.1. HIV
17.7.3.4.2.2. Hepatitis B
17.7.3.4.2.3. Hepatitis C
17.7.3.4.2.4. Pregnancy
17.7.3.4.2.5. Others
17.7.3.4.3.
Infectious
Diseases
17.7.3.4.3.1. RSV
17.7.3.4.3.2. Influenza
17.7.3.4.3.3. Streptococcus/Stepthroat
17.7.3.4.3.4. COVID-19 test
17.7.3.4.3.5. C-reactive protein (CRP) test(inflammation/infection)
17.7.3.4.3.6. Procalcitonin (PCT) test (sepsis/bacterial
infections)
17.7.3.4.3.7. Others
17.7.3.4.4.
Endocrine
(Diabetes)
17.7.3.4.4.1. Rapid blood glucose test
17.7.3.4.4.2. Hemoglobin A1c (HbA1c) test
17.7.3.4.4.3. Ketone
17.7.3.4.5.
Others
17.7.3.5.
Rest of
Latin America Rapid Tests Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.3.5.1.
Hospitals
and Clinics
17.7.3.5.2.
Laboratories
17.7.3.5.3.
At-home
testing
17.7.3.5.4.
Others
17.8. Key Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Type
17.8.3. By Format
17.8.4. By Product Type
17.8.5. By
Application
17.8.6. By End Users
18. Competitive Benchmarking
18.1. Brand Benchmarking
18.2. Market Share Analysis, 2022
18.3. Global Presence and Growth Strategies
18.3.1. Mergers and Acquisitions
18.3.2. Product Launches
18.3.3. Investments Trends
18.3.4. R&D Initiatives
19. Player Profiles
19.1. Abbott
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. Active Scientific Sdn Bhd.
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. Bio-Rad Laboratories, Inc.
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. Creative Diagnostics
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. CROWN CLINIC
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. F. Hoffmann-La Roche Ltd
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. Genes2Me
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. JOYSBIO (Tianjin) Biotechnology Co., Ltd
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. Malaysian Diagnostics Corporation.
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. Mediven
19.10.1. Company Details
19.10.2. Company Overview
19.10.3. Product Offerings
19.10.4. Key Developments
19.10.5. Financial Analysis
19.10.6. SWOT Analysis
19.10.7. Business Strategies
19.11. Precision Biomed
19.11.1. Company Details
19.11.2. Company Overview
19.11.3. Product Offerings
19.11.4. Key Developments
19.11.5. Financial Analysis
19.11.6. SWOT Analysis
19.11.7. Business Strategies
19.12. Prima Dinamik Supplies Sdn Bhd.
19.12.1. Company Details
19.12.2. Company Overview
19.12.3. Product Offerings
19.12.4. Key Developments
19.12.5. Financial Analysis
19.12.6. SWOT Analysis
19.12.7. Business Strategies
19.13. Robert Bosch Sdn Bhd
19.13.1. Company Details
19.13.2. Company Overview
19.13.3. Product Offerings
19.13.4. Key Developments
19.13.5. Financial Analysis
19.13.6. SWOT Analysis
19.13.7. Business Strategies
19.14. SEKISUI Diagnostics
19.14.1. Company Details
19.14.2. Company Overview
19.14.3. Product Offerings
19.14.4. Key Developments
19.14.5. Financial Analysis
19.14.6. SWOT Analysis
19.14.7. Business Strategies
19.15. Setia Scientific Solution
19.15.1. Company Details
19.15.2. Company Overview
19.15.3. Product Offerings
19.15.4. Key Developments
19.15.5. Financial Analysis
19.15.6. SWOT Analysis
19.15.7. Business Strategies
19.16. Other Market Participants
20. Key Findings
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
